C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.820
+0.120 (4.44%)
Apr 2, 2026, 4:00 PM EDT - Market closed
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $275.17 million as of April 2, 2026. Its market cap has increased by 81.13% in one year.
Market Cap
275.17M
Enterprise Value
38.05M
1-Year Change
81.13%
Ranking
Category
Stock Price
$2.82
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $275.17M, a decrease of -64.39%. That is a compound annual growth rate of -17.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 275.17M | 48.66% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 289.39M |
| Prelude Therapeutics | 285.57M |
| Silence Therapeutics | 280.57M |
| NovaBridge Biosciences | 280.16M |
| Anavex Life Sciences | 277.09M |
| Protara Therapeutics | 276.37M |
| Abeona Therapeutics | 274.98M |
| AC Immune | 273.80M |